Clinical trial of MBX 1416 for Post-Bariatric Hypoglycemia begins
The first participant has been dosed in MBX Biosciences’ Phase 1/2 clinical trial of MBX 1416, the company’s long-acting glucagon-like...
top of page
Browse by category
Search
Browse by tag
bottom of page